Most Popular
-
1
Hybe-Ador feud should have limited effect on Hybe's overall performance: analysts
-
2
Second Gimpo civil servant found dead, after apologizing for not finishing work
-
3
DP leader says he will meet Yoon without conditions
-
4
First-ever meeting of president, opposition chief set to finally happen
-
5
NewJeans' singles, Japanese debut to proceed as planned, despite Hybe-Ador feud
-
6
Blinken calls on China to press N. Korea to end its 'dangerous' behavior
-
7
Experts raise concerns about Japan putting pressure on Naver over Line
-
8
Samsung mobile chief, Google device head meet in Seoul
-
9
More med professors to take day off each week while govt. urges them to stay
-
10
South Korea to launch space security center under spy agency
Komipharm’s cancer-treating painkiller for animals approved in Australia
By 황유미Published : Sept. 8, 2016 - 15:46
[THE INVESTOR] Komipharm, a veterinary pharmaceutical company, announced on Sept. 7 that its PAX-1, trade name Kominox, has been granted permission for sale in Australia, in response to Korea Exchange’s inquiry regarding the company’s stock price surge.
Kominox is a nonopioid painkiller that also fights cancer and Australian Therapeutic Goods Administration has approved use of the medicine to treat progressive cancer patients with chronic pains through all stages, the company added.
By Hwang You-mee (glamazon@heraldcorp.com)
Kominox is a nonopioid painkiller that also fights cancer and Australian Therapeutic Goods Administration has approved use of the medicine to treat progressive cancer patients with chronic pains through all stages, the company added.
By Hwang You-mee (glamazon@heraldcorp.com)
